The People's Perspective on Medicine

Cancer Drug Shortages

0 - 0 ratings

Terry Graedon

February 23, 2012

1 Comment

Terry Graedon

February 23, 2012

1 Comment

Shortages of two essential cancer drugs have the FDA scrambling to find alternate sources. Supplies of methotrexate to treat childhood leukemia were critically low due to manufacturing problems in the U.S. The FDA has quickly given a German company the green light to provide preservative-free methotrexate. The other drug, doxorubicin, is made by a company in India. The hope is that these imports will cover the shortfall of these crucial chemotherapy agents.

Rate this article

0- 0 ratings

About the Author

Terry Graedon

Terry Graedon, PhD, is a medical anthropologist and co-host of The People’s Pharmacy radio show, co-author of The People’s Pharmacy syndicated newspaper columns and numerous books, and co-founder of The People’s Pharmacy website. Terry taught in the Duke University School of Nursing and was an adjunct assistant professor in the Department of Anthropology. She is a Fellow of the Society of Applied Anthropology. Terry is one of the country's leading authorities on the science behind folk remedies.Read Terry's full bio.

Tired of the ads on our website?

Now you can browse our website completely ad-free for just $5 / month. Stay up to date on breaking health news and support our work without the distraction of advertisements.

Join over 150,000 Subscribers at The People's Pharmacy

We're empowering you to make wise decisions about your own health, by providing you with essential health information about both medical and alternative treatment options.

The People's Perspective on Medicine

Cancer Drug Shortages

Tired of the ads on our website?

Content

About Us

Get In Touch